Business Context and Reporting Period
This Form 8-K Current Report is filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) for the reporting date of October 9, 2025. The filing documents the results of a Special Meeting of stockholders held on this date to approve corporate governance and capital structure amendments.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions and voting results rather than financial performance metrics.
Material Changes and Voting Results
At the Special Meeting, 3,907,536 shares were represented, constituting a quorum. Stockholders approved three key proposals:
- Authorized Share Increase: Approved authority for the Board to increase authorized common stock from 250,000,000 to between 500,000,000 and 1,000,000,000 shares.
- Votes For: 3,764,397
- Votes Against: 129,427
- Abstain: 13,711
- Equity Incentive Plan Amendment: Approved increasing shares reserved for the 2023 Omnibus Equity Incentive Plan from 792,602 to 2,000,000 shares.
- Votes For: 2,419,032
- Votes Against: 86,170
- Abstain: 3,265
- Broker Non-Votes: 1,399,069
- Future Offerings Proposal: Approved the issuance of securities in non-public offerings under Nasdaq Rules 5635(a) and 5635(d).
- Votes For: 2,419,243
- Votes Against: 87,306
- Abstain: 1,918
- Broker Non-Votes: 1,399,069
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, or specific risk factors. The primary operational implication is the Board's new discretion to increase authorized shares and the expanded capacity for equity-based compensation.
Investor Verification Checklist
- Verify the exact number of authorized shares the Board selects within the 500M–1B range approved.
- Review the full text of the Plan Amendment (Exhibit 10.1) for specific terms regarding the 2,000,000 share increase.
- Monitor future filings for the execution of non-public offerings under the approved Future Offerings Proposal.
- Confirm the company's ticker symbol is THAR on the Nasdaq Stock Market LLC.